Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » NWBT>>> Bottom Bounce (Page 3)

 - UBBFriend: Email this page to someone!   This topic comprises 3 pages: 1  2  3   
Author Topic: NWBT>>> Bottom Bounce
Fuzzy1018
Member


Rate Member
Icon 1 posted      Profile for Fuzzy1018     Send New Private Message       Edit/Delete Post   Reply With Quote 
agree tompom, .12 getting hit
Posts: 4071 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
bigpoppa
Member


Member Rated:
5
Icon 1 posted      Profile for bigpoppa     Send New Private Message       Edit/Delete Post   Reply With Quote 
its 12 already . YES!

--------------------
cuneyt dostlar

Posts: 53 | From: us | Registered: Oct 2006  |  IP: Logged | Report this post to a Moderator
tompom
Member


Member Rated:
4
Icon 1 posted      Profile for tompom     Send New Private Message       Edit/Delete Post   Reply With Quote 
this is looking better and better...
Posts: 2473 | Registered: May 2006  |  IP: Logged | Report this post to a Moderator
Fuzzy1018
Member


Rate Member
Icon 1 posted      Profile for Fuzzy1018     Send New Private Message       Edit/Delete Post   Reply With Quote 
volume's slow today compared to fri.
Posts: 4071 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
bigpoppa
Member


Member Rated:
5
Icon 1 posted      Profile for bigpoppa     Send New Private Message       Edit/Delete Post   Reply With Quote 
i think it needs time maybe after lunch it will grow in volume

--------------------
cuneyt dostlar

Posts: 53 | From: us | Registered: Oct 2006  |  IP: Logged | Report this post to a Moderator
Fuzzy1018
Member


Rate Member
Icon 1 posted      Profile for Fuzzy1018     Send New Private Message       Edit/Delete Post   Reply With Quote 
news out this morning
Posts: 4071 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
Fuzzy1018
Member


Rate Member
Icon 1 posted      Profile for Fuzzy1018     Send New Private Message       Edit/Delete Post   Reply With Quote 
NWBT .095

Northwest Biotherapeutics to Present at the 21st Annual Meeting of the International Society for Biological Therapy of Cancer
PR Newswire - October 26, 2006 8:28 AM (EDT)

DCVax(R)-Brain Clinical Data Update

BOTHELL, Wash., Oct 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Northwest Biotherapeutics (OTC Bulletin Board: NWBT.OB) announced today that Linda Liau M.D., Ph.D. and Robert Prins, Ph.D. of the Department of Neuro Surgery at University of California at Los Angeles (UCLA) will present an update on the clinical data from two Phase I DCVax(R)-Brain clinical trials, including ongoing long-term survival data, being carried out at UCLA under the direction of Dr. Liau, the principal investigator. The company continues to follow survivors (9 of 18 are still alive, 8 of which are cancer free) in these two trials with survival times in these patients ranging from 10 months to over 6 years. In addition, the company supports a booster program for these 9 patients. The presentation will take place Saturday, October 28th beginning at 9:00 AM Pacific Time during the annual meeting of the International Society for Biological Therapy of Cancer (iSBTc) held at the Hyatt Regency Century Plaza in Los Angeles.

About Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, on a cost-effective basis. The Company has two broad platform technologies: dendritic cell based vaccines, and therapeutic antibodies. The Company's three lead product candidates are:

DCVax(R)-Prostate, a personalized dendritic cell vaccine for treatment of hormone independent non-metastatic prostate cancer, which is entering a Phase III clinical trial; DCVax(R)-Brain, a personalized dendritic cell vaccine for treatment of newly diagnosed Glioblastoma multiforme, which is entering a large Phase II clinical trial; and CXCR4 a therapeutic monoclonal antibody in late preclinical development for the treatment of cancer. For further information and filing with the Securities and Exchange Commission, please visit the company web site at www.nwbio.com .

SOURCE Northwest Biotherapeutics, Inc.

Lorie Calvo, +1-425-608-3008, for Northwest Biotherapeutics

http://www.nwbio.com/

Copyright (C) 2006 PR Newswire. All rights reserved

Posts: 4071 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
Schwabie
Member


Icon 1 posted      Profile for Schwabie     Send New Private Message       Edit/Delete Post   Reply With Quote 
DELETED NEWS !

YOU BEAT ME TO IT !

[Eek!]

--------------------
All I say is IMHO.

I like these calm little moments before the storm... Reminds me of Bethoven

Posts: 3255 | From: Orlando, FL | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
Fuzzy1018
Member


Rate Member
Icon 1 posted      Profile for Fuzzy1018     Send New Private Message       Edit/Delete Post   Reply With Quote 
nice news, all we need is some volume
Posts: 4071 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
bigpoppa
Member


Member Rated:
5
Icon 1 posted      Profile for bigpoppa     Send New Private Message       Edit/Delete Post   Reply With Quote 
NO VOLUME YET!

--------------------
cuneyt dostlar

Posts: 53 | From: us | Registered: Oct 2006  |  IP: Logged | Report this post to a Moderator
  This topic comprises 3 pages: 1  2  3   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share